Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lexapro® (escitalopram) – Expanded indication
May 12, 2023 - The FDA approved AbbVie’s Lexapro (escitalopram), for the treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older.
